Skip to main content

Advertisement

Table 2 Correlation between AIM2, clinical characteristics, and lab findings in CHB group

From: Expression of AIM2 is correlated with increased inflammation in chronic hepatitis B patients

   AIM2   
  n + ++ +++ x 2 p
Male 30 1(3.3 %) 8(26.7 %) 10(33.3 %) 11(36.7 %) 5.351 0.148
Age(years)       4.918 0.178
 20–40 30 3(10.0 %) 9(30.0 %) 7(23.3 %) 11(36.7 %)   
 40–60 17 2(11.8 %) 1(5.9 %) 8(47.0 %) 6(35.3 %)   
ALT       39.987 0.030
 ULN-2ULN 32 5(15.6 %) 7(21.9 %) 9(28.1 %) 11(34.4 %)   
 2ULN-5ULN 15 0(0 %) 3(20.0 %) 6(40.0 %) 6(40.0 %)   
AST       36.487 0.378
 ULN-2ULN 38 4(10.5 %) 9(23.7 %) 12(31.6 %) 13(34.2 %)   
 2ULN-5ULN 9 1(11.1 %) 1(11.1 %) 3(33.3 %) 4(44.4 %)   
eAg       0.049 0.825
 Positive 26 3(11.5 %) 5(19.2 %) 9(34.6 %) 9(34.6 %)   
 Negative 21 2(9.5 %) 5(23.8 %) 6(28.6 %) 8(38.1 %)   
HBV DNA       25.96 <0.001
 ≥ 105copies/mL 25 0(0 %) 0(0 %) 10(40.0 %) 15(60.0 %)   
 < 105copies/mL 22 5(20.0 %) 10(40.0 %) 5(20.0 %) 2(8.0 %)   
  1. CHB chronic hepatitis B, ALT Alanine aminotransferase, AST Aspartate aminotransferase, ULN upper limits of normal